DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pentifylline
Pentifylline
(12) United States Patent (10) Patent No.: US 7.803,838 B2 Davis Et Al
勃起不能治療準則 賴依伶 毛箴言 林口長庚紀念醫院藥劑科 台北藥劑組 本稿譯自 European Association of Urology:GUIDELINES on ERECTILE DYSFUNCTION
Pharmaceutical Appendix to the Tariff Schedule 2
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
Stembook 2018.Pdf
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
2021 Equine Prohibited Substances List
Wo 2007/120485 A2
Oxpentifylline and Cetiedil Citrate Improve Deformability of Dehydrated Sickle Cells
Medical Product Quality Report – COVID-19 Issues
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Medical Product Quality Report – COVID-19 Issues
Systemic Therapy with Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease
'Cerebroactive' Drugs Clinical Pharmacology and Therapeutic Role in Cerebrovascular Disorders
Top View
Transdermal Device Containing
WO 2018/055211 Al 29 March 2018 (29.03.2018) W !P O PCT
Pharmaabkommen A1 E
Non-Target Screening ‒ a Powerful Tool for Selecting Environmental Pollutants
(12) United States Patent (10) Patent No.: US 8,354,116 B2 Carter Et Al
Customs Tariff - Schedule Xxi - 1
Pentoxifylline, Pentifylline, and Interferons Decrease Type I
WO 2015/120110 A2 13 August 2015 (13.08.2015) P O P C T
Isoxsuprine Elisa Kit Instructions Product #102219 & 102216 Forensic Use Only
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
(12) Patent Application Publication (10) Pub. No.: US 2010/0292280 A1 Zachar (43) Pub
Pentoxifylline Downregulates Profibrogenic Cytokines And
Investigação Da Eficácia Terapêutica De Compostos Com Atividade Anti
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary Table 1. All Compounds Causing BLI Enhancement
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Harmonized Tariff Schedule of the United States (2006) (Rev